|
|
||||||||
1Division of Pulmonary & Critical Care Medicine, Department of Medicine, Northwestern University, Chicago, Illinois; and 2Department of Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine, Osaka, Japan
Submitted 14 September 2004 ; accepted in final form 27 April 2005
Exposure to bleomycin in rodents induces lung injury and fibrosis. Alveolar epithelial cell death has been hypothesized as an initiating mechanism underlying bleomycin-induced lung injury and fibrosis. In the present study we evaluated the contribution of mitochondrial and receptor-meditated death pathways in bleomycin-induced death of mouse alveolar epithelial cells (MLE-12 cells) and primary rat alveolar type II cells. Control MLE-12 cells and primary rat alveolar type II cells died after 48 h of exposure to bleomycin. Both MLE-12 cells and rat alveolar type II cells overexpressing Bcl-XL did not undergo cell death in response to bleomycin. Dominant negative Fas-associating protein with a death domain failed to prevent bleomycin-induced cell death in MLE-12 cells. Caspase-8 inhibitor CrmA did not prevent bleomycin-induced cell death in primary rat alveolar type II cells. Furthermore, fibroblast cells deficient in Bax and Bak, but not Bid, were resistant to bleomycin-induced cell death. To determine whether the stress kinase JNK was an upstream regulator of Bax activation, MLE-12 cells were exposed to bleomycin in the presence of an adenovirus encoding a dominant negative JNK. Bleomycin-induced Bax activation was prevented by the expression of a dominant negative JNK in MLE-12 cells. Dominant negative JNK prevented cell death in MLE-12 cells and in primary rat alveolar type II cells exposed to bleomycin. These data indicate that bleomycin induces cell death through a JNK-dependent mitochondrial death pathway in alveolar epithelial cells.
Bax; c-Jun NH2-terminal kinase; apoptosis; lung; fibrosis
This article has been cited by other articles:
![]() |
R. A. Stetler, G. Cao, Y. Gao, F. Zhang, S. Wang, Z. Weng, P. Vosler, L. Zhang, A. Signore, S. H. Graham, et al. Hsp27 Protects against Ischemic Brain Injury via Attenuation of a Novel Stress-Response Cascade Upstream of Mitochondrial Cell Death Signaling J. Neurosci., December 3, 2008; 28(49): 13038 - 13055. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pagano, I. Metrailler-Ruchonnet, M. Aurrand-Lions, M. Lucattelli, Y. Donati, and C. B. Argiroffo Poly(ADP-ribose) polymerase-1 (PARP-1) controls lung cell proliferation and repair after hyperoxia-induced lung damage Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L619 - L629. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-R. Kang, S. J. Cho, C. G. Lee, R. J. Homer, and J. A. Elias Transforming Growth Factor (TGF)-beta1 Stimulates Pulmonary Fibrosis and Inflammation via a Bax-dependent, Bid-activated Pathway That Involves Matrix Metalloproteinase-12 J. Biol. Chem., March 9, 2007; 282(10): 7723 - 7732. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Sydlik, K. Bierhals, M. Soufi, J. Abel, R. P. F. Schins, and K. Unfried Ultrafine carbon particles induce apoptosis and proliferation in rat lung epithelial cells via specific signaling pathways both using EGF-R Am J Physiol Lung Cell Mol Physiol, October 1, 2006; 291(4): L725 - L733. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. S. Budinger, G. M. Mutlu, J. Eisenbart, A. C. Fuller, A. A. Bellmeyer, C. M. Baker, M. Wilson, K. Ridge, T. A. Barrett, V. Y. Lee, et al. Proapoptotic Bid is required for pulmonary fibrosis PNAS, March 21, 2006; 103(12): 4604 - 4609. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |